A carregar...

Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice

Sodium glucose cotransporter-2 (SGLT2) inhibitors inhibit the development of diabetic nephropathy (DN). We determined whether changes in perirenal fat (PRAT) by a SGLT2 inhibitor ipragliflozin (Ipra) contribute to the suppression of DN development. High-fat diet (HFD)-fed mice were used as a DN mode...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Okuma, Hideyuki, Mori, Kentaro, Nakamura, Suguru, Sekine, Tetsuo, Ogawa, Yoshihiro, Tsuchiya, Kyoichiro
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8304702/
https://ncbi.nlm.nih.gov/pubmed/34298949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22147329
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!